When Science Isn't Enough: Wilhelm Hueper, Robert A. M. Case, and the Limits of Scientific Evidence in Preventing Occupational Bladder Cancer

References

• Ward E, Carpenter A, Markowitz S, Roberts D, Halperin W. Excess number of bladder cancers in workers exposed to orthotoluidine and aniline. J Natl Cancer Inst. 1991; 83: 501–6.
   PubMed Web of Science ®Google Scholar
• Hueper WC. Occupational and Environmental Cancers of the Urinary System. New Haven, Connecticut: Yale University Press, 1969.
   Google Scholar
• Temkin IS. Industrial Bladder Carcinogenesis. New York: Pergamon Press, 1963.
   Google Scholar
• You XY, Chen JG, Hu YN. Studies on the relation between bladder cancer and benzidine or its derived dyes in Shanghai. Br J Ind Med. 1990; 47: 544.-52.
   Google Scholar
• BI W, Hayes RB, Feng P, et al. Mortality and incidence of bladder cancer in benzidineexposed workers in China. Am J Ind Med. 1992; 21: 481–9.
   PubMed Web of Science ®Google Scholar
• Menon AS. A preliminary study of health hazards in the small scale dyestuff industry of Ahmedabad. Ind J Ind Med. 1980; 28: 500–6.
   Google Scholar
• Dewan A, Jani JP, Shah KS, Kashyap SK. Urinary excretion of benzidine in relation to the acetylator status of occupationally exposed subjects. Hum Toxicol. 1986; 5: 95–7.
   PubMedGoogle Scholar
• Notani PN, Shah P, Jayant K, Balakrishnan V. Occupation and cancers of the lung and bladder: a casecontrol study in Bombay. Int J Epidemiol. 1993; 22: 185–91.
   PubMed Web of Science ®Google Scholar
• Scott TS. Carginogenic and chronic toxic hazards of aromatic amines. Amsterdam, The Netherlands: Elsevier Publishing Com-pany, 1962.
   Google Scholar
• Norton TH. Dyestuffs for American Textile and Other Industries. U.S. Department of Commerce. Special Agent Series No. 96. Washington, D.C.: Government Printing Office, 1915.
   Google Scholar
• Borldn J, Welsh CH. Germany's Master Plan: The Story of Industrial Offensive. New York: Duell, Sloan and Pearce, 1943.
   Google Scholar
• U.S. Tariff Commission. Dyes: War Changes in Industry Series. Report No. 19. Washington, D.C.: Government Printing Office, 1946.
   Google Scholar
• Beeril. The Emergence of the German Dye Industry. Urbana, Illi-nois: University of Illinois Press, 1959.
   Google Scholar
• International Labour Office. Cancer of the Bladder among Workers in Aniline Factories. Studies and Reports Series F, Number 1. Geneva, Switzerland, 1921.
   Google Scholar
• E. I. duPont de Nemours & Co. Du Pont: The Autobiography of an American Enterprise. New York: Charles Scribner's Sons, 1952.
   Google Scholar
• Hounshell DA, Smith JK. Science and corporate strategyDuPont R&D, 1902-1980. Cambridge, U.K.: Cambridge University Press, 1988.
   Google Scholar
• Rosner D, Markowitz G. A “gift of God?": the public health controversy over leaded gasoline in the 1920s. Am J Public Health. 1985; 75: 344–51.
   PubMed Web of Science ®Google Scholar
• Gehrmann GH. The carcinogenic agentchemistry and industrial aspects. J Urol. 1934; 31: 126–37.
   Google Scholar
• Evans EE. Causative agents and protective measures in the anilin tumor of the bladder. J Urol. 1936; 38: 212–5.
   Google Scholar
• Washburn VD. Abstract of discussion. JAMA. 1936; 107: 1438–9.
   Google Scholar
• Smith DT. History of beta naphthylamine manufacture-Cham-bers Works. Du Pont Confidential Memo, September 22,1958.
   Google Scholar
• Young M, Russell WT. An investigation into the statistics of cancer in different trades and professions. London, U.K: Medical Research Council, 1926.
   Google Scholar
• Bridge JC, Henry SA. Industrial Cancers. Proceedings of the International Cancer Conference. London, U.K.: Wright Bristol, 1928.
   Google Scholar
• Wignall TH. Incidence of disease of the bladder in workers in certain chemicals. Br Med J. 1929; 2: 291–3.
   PubMedGoogle Scholar
• Borkin J. The Crime and Punishment of I. G. Farben. New York: The Free Press, 1978.
   Google Scholar
• Epstein SS. Presentation of the first annual award of the Society for Occupational and Environmental Health to Dr. Wilhelm C. Hueper. Ann NY Acad Sci. 1975; 271: 457–9.
   Google Scholar
• Hueper WC. Unpublished manuscript. Washington, D.C.: National Library of Medicine (undated).
   Google Scholar
• Hueper WC, Wiley FII, Wolfe HD. Experimental production of bladder tumors in dogs by administration of beta-naphthylamine. J Ind Hyg Toxicol. 1938; 20: 46–84.
   Google Scholar
• Breslow L. A History of Cancer Control in the United States 1946-1971. Appendix 9. DHEW Pub. No. (N11-1) 79-1519,1979.
   Google Scholar
• Hueper WC. Occupational Tumors and Allied Diseases. Spring-field, Illinois: Charles C. Thomas, 1942.
   Google Scholar
• Agran L. The Cancer Connection. Boston, Massachusetts: Houghton Mifflin, 1977.
   Google Scholar
• Case RAM. The Misbegotten Camel. Unpublished manuscript, 1983.
   Google Scholar
• Case RAM. Tumors of the urinary tract as an occupational disease in several industries. Ann Roy Coll Surg. 1966; 39: 213–35.
   PubMedGoogle Scholar
• Case RAM. Incidence of death from tumours of the urinary blad-der. Br J Prey Soc Med. 1953; 7: 14–9.
   PubMedGoogle Scholar
• Checkoway H, Pearce NE, Crawford-Brown DJ. Research Methods in Occupational Epidemiology. New York: Oxford University Press, 1989.
   Google Scholar
• Case RAM, Hosker ME, McDonald DB, Pearson JT. Tumours of the urinary bladder in workmen engaged in the manufacture and use of certain dyestuff intermediates in the British chemical in-dustry: Part I. The role f aniline, benzidine, alpha-naphthylamine, and beta-naphthylamine. Br J Ind Med. 1954; 11: 75–96.
   Google Scholar
• Case RAM, Hosker ME. Tumour of the urinary bladder as an occupational disease in the rubber industry in England and Wales. Br J Prey Soc Med. 1954; 48: 39–50.
   Google Scholar
• Gehrmann GH, Foulger, JH, Fleming AJ. Occupational Carcinoma of the Bladder. Ninth International Congress on Industrial Medicine. London, U.K.: Bristol Wright, 1949: 472–475.
   Google Scholar
• Case RAM. “Corporate Criminal Liability.” Hearings before the Subcommittee on Crime of the Committee on the Judiciary, U.S. House of Representatives 1981; 71: 101–3.
   Google Scholar
• Castleman B. DuPont & Record in Business Ethics: Another View. Washington Post, July 15,1979:E4.
   Google Scholar
• Fleming AJ, D'Alonzo CA, Zapp JA. Modern Occupational Medi-cine. Philadelphia, Pennsylvania: Lea & Febiger, 1954.
   Google Scholar
• Mason TJ, Prorock PC, Neeld WE, Vogler WJ. Screening for bladder cancer at the DuPont Chambers Works: initial findings. J Occup Med. 1986; 28: 1011–6.
   PubMedGoogle Scholar
• Walker B, Gerber A. Occupational exposure to aromatic amines: benzidine and benzidinebased dyes. Nail Cancer Inst Monogr. 1981; 58: 11–3.
   PubMedGoogle Scholar
• National Institute for Occupational Safety and Health. Special occupational hazard review for benzidinebased dyes. DHEW (NIOSH) Pub. No. 80-109. Washington, D.C.: Government Printing Office, 1980.
   Google Scholar
• Samuels SW. The international context of carcinogen regulation: benzidine. in Cold Spring Harbor, NY: Banbury Rep. 1981; 9: 497–512.
   Google Scholar
• Fishbein L. Aromatic amines of major industrial importance: use and occurrence. In: Egan H (ed): Some Aromatic Amines and Azo Dyes in the General and Industrial Environment. Lyon, France: IARC Sci Publ No. 40: 3–113,1981.
   PubMedGoogle Scholar
• Borneff J. Carcinoma of the bladder found in workers employed in tar distilleries. Zentralb Arbeitsmed Arbeitsschutz. 1965; 15: 288–92.
   PubMedGoogle Scholar
• Khlebnikova MI, Gladkova Y, Kurenko LT, Pshenitsyn AV, Shalin BM. Problems of labor hydiene and the state of health of workers in the production of o-toluidine. Gorky, Russia: Institute of Labor Hygiene and Occuptional Diseases, 1976.
   Google Scholar
• Rubino GF, Scansetti G, Piolatto G, Pira E. The carcinogenic effect of aromatic amines: an epidemiological study on the role of otoluidine and 4,4'-methylene bis (2-methylaniline) in inducing bladder cancer in man. Envion Res. 1982; 27: 241–54.
   PubMed Web of Science ®Google Scholar
• Morigami S, Nisimura I. Experimental studies on aniline bladder tumors. GANN. 1940; 34: 146–7.
   Google Scholar
• Satani Y, Tanimura T, Nishimura I, Isekawa Y. Clinical and experimental examination of bladder papillomas. GANN. 1941; 35: 275–6.
   Google Scholar
• Strombeck JP. Azotoluene bladder tumors in rats. J Pathol Bacte-riol. 1946; 58: 275–8.
   PubMedGoogle Scholar
• Ekman B, Strombeck JP. Demonstration of tumorigenic decomposition products of 2,3-azotoluene. Acta Physiol Scand. 1947; 14: 43–50.
   PubMedGoogle Scholar
• Homburger F, Friedell GH, Weisburger EK, Weisburger JH. Car-cinogenicity of simple aromatic amine derivatives in mice and rats. Toxicol Appl Pharrnacol. 1972; 22: 280–1.
   Web of Science ®Google Scholar
• Russfield AB, Homburger FGH, Weisburger JH, Weisburger EK Further studies on carcinogenicity of environmental chemicals including simple aromatic amines. ToxicOl Appl Pharmacol. 1973; 25: 446–7.
   Web of Science ®Google Scholar
• U.S. National Cancer Institute. Bioassay of oToluidine Hydrochloride for Possible Carcinogenicity. DHEW Pub. No. (NIH) 79-1709, 1979.
   Google Scholar
• International Agency for Research on Cancer. IARC Monographs on the Evaluation of the Carcinogenic Risk of Chemicals to Hu-mans. Volume 27: Some Aromatic Amines, Anthraquinones and Nitroso Compounds, and Inorganic Fluorides Used in Drinking-water and Dental Preparations. Lyon, France: IARC, 1982.
   Google Scholar
• Johnson WM, Panes WD. Beta-naphthylamine and benzidine: identification of groups at high risk of bladder cancer. Ann NY Acad Sci. 1979; 329: 277–84.
   Web of Science ®Google Scholar
• Goldwater 4j, Rosso LA, Kleinfeld M. Bladder tumors in a coal tar dye plant. Arch Environ Health. 1965; 11: 814–7.
   PubMedGoogle Scholar
• Spitz S, Maguigan WH, Dobriner K. The carcinogenic action of benzidine. Cancer. 1950; 3: 789–804.
   PubMed Web of Science ®Google Scholar
• Maguigan WH. Occupational bladder tumors. Acta Unio International Contra Cancrum. 1950;6(suppl):1359–64.
   Google Scholar
• U.S. National Institute for Occupational Safety and Health. Field Survey of Allied Chemical Corporation. Specialty Chemical Divi-sion, Buffalo, New York, October 16,1972.
   Google Scholar
• Ferber KR Hill WJ, Cobb DA. An assessment of the effect of improved working conditions on bladder tumor incidence in a benzidine manufacturing facility. Am Ind Hyg Assoc J. 1976; 37: 61–8.
   Google Scholar
• Erni P. The Basel marriage: history of the CibaGeigy merger. Zurich, Switzerland: Ciba-Geigy, 1979.
   Google Scholar
• Scott TS. The incidence of bladder tumours in a dyestuffs factory. Br J Ind Med. 1952; 9: 127–32.
   PubMedGoogle Scholar
• Zavon M, Hoegg U, Bingham B. Benzidine exposure as a cause of bladder tumors. Arch Environ Health. 1973; 27: 1–7.
   PubMedGoogle Scholar
• Mancuso TF, El-Attar AA. Cohort study of workers exposed to betanaphthylamine and benzidine. J Occup Med. 1967; 9: 277–85.
   PubMedGoogle Scholar
• Rye WA, Woolrich PF, Zanes RP. Facts and myths concerning aromatic diamine curing agents. J Occup Med. 1970; 12: 211–5.
   PubMedGoogle Scholar
• Meigs JVV, Brown RM, Sciarini U. A study of exposure to benzidine and substituted benzidines in a chemical plant. Arch Ind Hyg Occup Med. 1951; 4: 533–40.
   PubMedGoogle Scholar
• Kleinfeld M. Cancer of the urinary bladder in a dye plant. In: Deichmann WB, Lampe KF (eds): Bladder Cancer: A Symposium. Birmingham, Alabama: Aesculapius. 1967: 136–43.
   Google Scholar
• Markowitz S, Lyons C. Bladder cancer at Bound Brook: malignant neglect. New York: Montefiore Medical Center Report, 1979.
   Google Scholar
• Lieben J. An epidemiological study of occupational bladder can-cer. Acta Unio International Contra Cancrum. 1963; 19: 749–50.
   PubMedGoogle Scholar
• Schulte PA, Ringen K, Hemstreet GP, et al. Risk assessment of a cohort exposed to aromatic amines: initial results. J Occup Med. 1985; 27: 115–21.
   PubMedGoogle Scholar
• Stern FB, Murthy LL, Beaumont JJ, Schulte PA, Halperin WE. No-tification and risk assessment for bladder cancer of a cohort exposed to aromatic amines: III. Mortality among workers exposed to aromatic amines in the last betanaphthylamine manufacturing facility in the United States. J Occup Med. 1985; 27: 495–500.
   Google Scholar